TELLAPRIALBI

The APRI and ALBI scores are commonly used in clinical routine to assess the severity of illness for patients suffering from hepatic tumors and to predict postoperative liver dysfunction after resection. Combining these scores, the APRI+ALBI score provides even better performance of assessment and prediction regarding 30-day-mortality after surgery.

TELLAPRIALBI allows you to
- enter relevant lab parameters (platelet count, AST, albumin and bilirubin levels)
- automatically compute APRI, ALBI and APRI+ALBI scores for comparative review
- select from a variety of tumor types together with the respective extent of resection and
- view clinical interpretation plots regarding 30-day-mortality post operation highlighting the risk class indicated by the APRI+ALBI score.

The app is intended for educational use by medical professionals and to allow review of the APRI+ALBI score and its predictive quality. All information entered into the app and computed by it is processed exclusively within the app on the user's device and no information is stored, transmitted or shared by the app.

TELLAPRIALBI was developed jointly by the Translational Experimental Liver Laboratory at the Medical University of Vienna (TELLVIENNA) and 37binary UG (haftungsbeschränkt). It is based on a joint research paper which is currently in print at BMJ Open. The app is published by and the service is provided by 37binary UG (haftungsbeschränkt).
Read more
Collapse
Loading…

What's New

Initial release: Check out the APRI+ALBI score for hepatic tumor resection stratification.
Read more
Collapse

Additional Information

Updated
January 12, 2021
Size
19M
Installs
5+
Current Version
1.2.1
Requires Android
5.0 and up
Content Rating
Everyone
Permissions
Offered By
37binary
©2021 GoogleSite Terms of ServicePrivacyDevelopersAbout Google|Location: United StatesLanguage: English (United States)
By purchasing this item, you are transacting with Google Payments and agreeing to the Google Payments Terms of Service and Privacy Notice.